Lilly to Open Genetic Research Institute in Boston
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says it will invest $700 million to establish the Lilly Institute for Genetic Medicine in Boston to accelerate the development of RNA and DNA-based medicines. ... Read More
